About | Free Trial

Last Update

2016-03-27T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong David Gibson?

Mr. David Gibson S. Jr.

Lecturer In Stratified Medicine

Vice-Chancellor

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Vice-Chancellor

Background Information

Employment History

Director

MNO Media

Lecturer In Stratified Medicine, BSc Hons Course Director

Ulster University

Biochip Research Scientist

Randox Laboratories Ltd

FX Reconciliations - Senior Bank Official

Ulster Bank Limited

Director and Secretary

56th FIM Motorcycle Rally, Killarney, Ireland

Affiliations

Senior Teaching Fellow
Queen’s University Belfast

Teaching Fellow
NICENT

Senior Teaching Fellow In Entrepreneurship
School of Management and Economics at Queen

Board Member
Enterprise Educators UK

Education

Ph.D.

Centre for Cancer Research and Cell Biology

Web References (175 Total References)


David Gibson with the ...

www.queens-belfast.ac.uk [cached]

David Gibson with the Vice-Chancellor collecting his award for Most Innovative Teacher of the Year

...
David Gibson with the Vice-Chancellor collecting his award for Most Innovative Teacher of the Year Photograph by Charles Fox
...
At the Times Higher Education (THE) awards ceremony in London last night David Gibson, a Senior Teaching Fellow in the Queen's University Management School, received the Most Innovative Teacher of the Year title. The award recognises the academic whose imagination and passion have transformed a course and inspired students.
This is the fourth consecutive year that Queen's University has been recognised at the THE Awards. The University received the Times Higher Excellence and Innovation in the Arts in 2008, THE Entrepreneurial University of the Year in 2009, and THE Outstanding Engineering Research Team of the Year in 2010. David Gibson's award of the Most Innovative Teacher of the Year is further recognition of the spirit of innovation and enterprise at Queen's that underpins its exceptional research and teaching.
Congratulating Mr Gibson, Queen's Vice-Chancellor Professor Sir Peter Gregson said: "This honour recognises the vital work which David and his colleagues carry out to nurture entrepreneurial skills among all our students, and builds upon his award earlier in the year as Global Entrepreneurship Educator.
...
In their citation, the judges said: "David has made enterprise studies into a reality to over 30,000 students in subjects as diverse as history and physics. "His strong focus on student engagement, his genuine cross-discipline approach and his ground-breaking model of venture-based learning have had an impact not only locally but also in universities across the world."
In 2003 David Gibson introduced a new curriculum-based Certificate in Entrepreneurship Studies at Queen's University Belfast. The aims were to embed entrepreneurship skills into the curriculum of all non-business students throughout the University, and for students to develop "enterprise for life" skills. His unique teaching model, called "venture-based learning", allowed students to develop real-life business and social enterprises, and to reflect and learn from their success or failure.
In 2010-11, Mr Gibson's teaching model was adopted by the European Training Foundation to enhance the employability of graduates across the EU by providing them with enterprise, business and entrepreneurial skills.
The award is the latest accolade for David Gibson. Earlier this year he was named the world's 'number one' enterprise educator by the United States Association of Small Business and Entrepreneurship.


Gibson, David Dr - Biomedical Sciences

samsara.scic.ulst.ac.uk [cached]

After his Biochemistry degree, Dr David Gibson worked at Randox Laboratories Ltd, where he was responsible for designing and commercializing novel biochip array diagnostic tests. He was awarded a Ph.D. in 2001 from the Centre for Cancer Research and Cell Biology, Queen's University Belfast, for research which exposed the role of cysteine proteinases in brain tumour invasion. During a Wellcome Trust Fellowship Dr Gibson investigated the role of inflammation in a hypoxia driven model of diabetic retinopathy at the Centre of Vision and Vascular Science, QUB.

Since 2003 Dr Gibson focused his research efforts on the discovery and validation of protein biomarkers which could improve the management of arthritis patients. During his time at the Rooney laboratory in the Centre of Infection and Immunity, QUB he spearheaded the use of proteomic and bioinformatic strategies to identify a plasma and synovial fluid protein 'fingerprint' that predicts disease spread in children with arthritis. He also identified post translational modifications in the Vitamin D binding protein that may act as a modulator of inflammation in juvenile arthritis patients.
In 2009, Dr Gibson was awarded a prestigious travel fellowship from Arthritis Research UK to conduct research at the Duncan laboratory at the University of Colorado, Denver over two years. From this fellowship Dr Gibson brings expertise in mass spectrometry analyses of clinically relevant proteins, peptides and post-translational modifications to his current post at the University of Ulster.
Research Interests
Stratified Medicine- 'the right treatment, for the right person, at the right time'
In 2013 Dr Gibson took up his post as Lecturer in Stratified Medicine and his research is focused on adult rheumatoid arthritis (RA). He is particularly interested in the development of new prognostic and predictive tools to improve the clinical management of arthritis patients. David's current research within the Northern Ireland Centre for Stratified Medicine is based at C-TRIC within the Altnagelvin Hospital campus, Londonderry.
He employs novel mass spectrometry based methods to robustly identify and quantify disease associated proteins. These methods are useful to investigate the role of protein modification in arthritis, as a surrogate measure of inflammatory activity. He is also interested in the application of protein array technologies for autoantibody screening. He will initially establish research programmes in three key areas: 1. How RA patients develop resistance to biologic therapies. 2. How inflammation and joint destruction can persist without clinical symptoms. 3. Can alternate methods of blood sampling support patient care away from the hospital clinic. Ultimately, Dr Gibson will develop novel monitoring tools to help clinicians target those patients who do not respond well to current therapeutics or develop drug resistance over time.
...
Dr David Gibson Lecturer in Stratified Medicine Biomedical Sciences Research Institute
...
Collins, ES, Butt, AQ, Gibson, DS, Dunn, M, Fearon, U, van Kuijk , AW, Gerlag , DM, Pontifex, E, Veale , DJ, Tak, PP, Fitzgerald, O and Pennington , SR (2015) A Clinically Based Protein Discovery Strategy to Identify Potential Biomarkers of Response to Anti-TNF-alpha Treatment of Psoriatic Arthritis. Proteomics Clinical Applications, ?.
Butt, Aisha Q, McArdle, Angela, Gibson, David, Fitzgerald, Oliver and Pennington, Stephen R (2015) Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management. Current Rheumatology Reports, 17 (5). pp. 509.
Bian, X, Wiktor, P, Kahn, P, Khela , A, Karthikeyan, K, Barker, K, Yu, X, Magee, M, Wasserfall, CH, Gibson, David, Rooney, ME, Qiu, J and LaBaer, J (2015) Anti-viral antibody profiling by high density protein arrays.. Proteomics, Tbc.
...
Duncan, Mark W, Gibson, David , Walsh, Ryan, Massod, Afsham and Benabdelkamel, Hicham (2014) An Overview of Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry and Some of Its Applications. In: Detection of Chemical, Biological, Radiological and Nuclear Agents for the Prevention of Terrorism, NATO Science for Peace and Security Series A: Chemistry and Biology. Springer Science, Dordrecht, Germany, pp. 69-81. ISBN 978-94-017-9237-0
Alfadda , AA, Turjoman , AA, Moustafa , AS, Al-Naami , MY, Chishti , MA, Sallam , RM, Gibson, David and Duncan, MW (2014) A proteomic analysis of excreted and circulating proteins from obese patients following two different weight-loss strategies. Exp Biol Med , 239 (5). pp. 568-580.
Shyamsundar , M, McAuley , DF, Ingram , RJ, Gibson, David, O'Kane , D, McKeown , ST, Edwards , A, Taggart , C, Elborn , JS, Calfee , CS, Matthay, MA and O'Kane , CM (2014) Keratinocyte Growth-Factor Promotes Epithelial Survival and Resolution in a Human Model of Lung Injury. Am J Respir Crit Care Med, 189 (12). pp. 1520-1529.
Ball, EM, Gibson, David, Bell, AL and Rooney, MR (2014) Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus.. Lupus, 23 (1). pp. 45-56.
Finnegan, S, Robson, J, Scaife, C, McAllister, C, Pennington, SR, Gibson, David and Rooney, ME (2014) Synovial membrane protein expression differs between juvenile idiopathic arthritis subtypes in early disease. Arthritis Research and Therapy, 16 (1). pp. R8.
...
Duncan, Mark and Gibson, David (2012) Mass Spectrometry for Peptide and Protein Analysis. In: Encyclopedia of Analytical Chemistry. John Wiley & Sons, Ltd., Encyclopedia of Analytical Chemistry, pp. 1-22. ISBN ISBN: 9780470027318
...
Pattison, Sally, Johnston, E, Gibson, David, Pappin , D and Elborn, JS (2012) Proteomic analysis of the chronically infected CF airways. In: 35th European Cystic Fibrosis Conference, Dublin, Ireland. Elsevier B.V..
Gibson, David, Newell, Keri, Evans, Alexandra, Finnegan, Sorcha, Manning, Gwen, Scaife, Caitiona, McAllister, Catherine, Pennington, Stephen, Duncan, Mark, Moore, Terry and Rooney, Madeleine (2012) Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis. Journal of Proteomics, 75. pp. 5479-5492.
Gibson, David, Rooney, Madeleine, Finnegan, Sorcha, Qiu, Ji, Thompson, David, LaBaer, Joshua, Pennington, Stephen and Duncan, Mark (2012) Biomarkers in rheumatology, now and in the future. Rheumatology (Oxford), 51. pp. 423-433.
Gibson, David and Jordan, Grant (2012) AN INVESTIGATION INTO THE USE OF HUMAN BONE MARROW OSTEOGENIC CELLS IN THE TREATMENT OF BONE DEFECTS. In: British Orthopaedic Research Society (BORS), Cardiff, Wales, 12 - 13 July 2010. BRITISH EDITORIAL SOCIETY OF BONE AND JOINT SURGERY .
Finnegan, Sorcha, Clarke, Susan, Gibson, David, McAllister, Catherine and Rooney, Madeleine (2011) Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups. Annals of the Rheumatic Diseases, 70. pp. 1842-1850.
Duncan, MW and Gibson, David (2011) Intact Protein Quantification by Mass Spectrometry . In: Mass Spectrometry Applications to the Clinical Lab, San Diego, CA, USA. MSACL, Inc. 281-282


Gibson, David Dr - Biomedical Sciences

bioinformatics.ulster.ac.uk [cached]

After his Biochemistry degree, Dr David Gibson worked at Randox Laboratories Ltd, where he was responsible for designing and commercializing novel biochip array diagnostic tests. He was awarded a Ph.D. in 2001 from the Centre for Cancer Research and Cell Biology, Queen's University Belfast, for research which exposed the role of cysteine proteinases in brain tumour invasion. During a Wellcome Trust Fellowship Dr Gibson investigated the role of inflammation in a hypoxia driven model of diabetic retinopathy at the Centre of Vision and Vascular Science, QUB.

Since 2003 Dr Gibson focused his research efforts on the discovery and validation of protein biomarkers which could improve the management of arthritis patients. During his time at the Rooney laboratory in the Centre of Infection and Immunity, QUB he spearheaded the use of proteomic and bioinformatic strategies to identify a plasma and synovial fluid protein 'fingerprint' that predicts disease spread in children with arthritis. He also identified post translational modifications in the Vitamin D binding protein that may act as a modulator of inflammation in juvenile arthritis patients.
In 2009, Dr Gibson was awarded a prestigious travel fellowship from Arthritis Research UK to conduct research at the Duncan laboratory at the University of Colorado, Denver over two years. From this fellowship Dr Gibson brings expertise in mass spectrometry analyses of clinically relevant proteins, peptides and post-translational modifications to his current post at the University of Ulster.
Research Interests
Stratified Medicine- 'the right treatment, for the right person, at the right time'
In 2013 Dr Gibson took up his post as Lecturer in Stratified Medicine and his research is focused on adult rheumatoid arthritis (RA). He is particularly interested in the development of new prognostic and predictive tools to improve the clinical management of arthritis patients. David's current research within the Northern Ireland Centre for Stratified Medicine is based at C-TRIC within the Altnagelvin Hospital campus, Londonderry.
He employs novel mass spectrometry based methods to robustly identify and quantify disease associated proteins. These methods are useful to investigate the role of protein modification in arthritis, as a surrogate measure of inflammatory activity. He is also interested in the application of protein array technologies for autoantibody screening. He will initially establish research programmes in three key areas: 1. How RA patients develop resistance to biologic therapies. 2. How inflammation and joint destruction can persist without clinical symptoms. 3. Can alternate methods of blood sampling support patient care away from the hospital clinic. Ultimately, Dr Gibson will develop novel monitoring tools to help clinicians target those patients who do not respond well to current therapeutics or develop drug resistance over time.
...
Dr David Gibson Lecturer in Stratified Medicine Biomedical Sciences Research Institute
...
Collins, ES, Butt, AQ, Gibson, DS, Dunn, M, Fearon, U, van Kuijk , AW, Gerlag , DM, Pontifex, E, Veale , DJ, Tak, PP, Fitzgerald, O and Pennington , SR (2015) A Clinically Based Protein Discovery Strategy to Identify Potential Biomarkers of Response to Anti-TNF-alpha Treatment of Psoriatic Arthritis. Proteomics Clinical Applications, ?.
Butt, Aisha Q, McArdle, Angela, Gibson, David, Fitzgerald, Oliver and Pennington, Stephen R (2015) Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management. Current Rheumatology Reports, 17 (5). pp. 509.
Bian, X, Wiktor, P, Kahn, P, Khela , A, Karthikeyan, K, Barker, K, Yu, X, Magee, M, Wasserfall, CH, Gibson, David, Rooney, ME, Qiu, J and LaBaer, J (2015) Anti-viral antibody profiling by high density protein arrays.. Proteomics, Tbc.
...
Duncan, Mark W, Gibson, David , Walsh, Ryan, Massod, Afsham and Benabdelkamel, Hicham (2014) An Overview of Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry and Some of Its Applications. In: Detection of Chemical, Biological, Radiological and Nuclear Agents for the Prevention of Terrorism, NATO Science for Peace and Security Series A: Chemistry and Biology. Springer Science, Dordrecht, Germany, pp. 69-81. ISBN 978-94-017-9237-0
Alfadda , AA, Turjoman , AA, Moustafa , AS, Al-Naami , MY, Chishti , MA, Sallam , RM, Gibson, David and Duncan, MW (2014) A proteomic analysis of excreted and circulating proteins from obese patients following two different weight-loss strategies. Exp Biol Med , 239 (5). pp. 568-580.
Shyamsundar , M, McAuley , DF, Ingram , RJ, Gibson, David, O'Kane , D, McKeown , ST, Edwards , A, Taggart , C, Elborn , JS, Calfee , CS, Matthay, MA and O'Kane , CM (2014) Keratinocyte Growth-Factor Promotes Epithelial Survival and Resolution in a Human Model of Lung Injury. Am J Respir Crit Care Med, 189 (12). pp. 1520-1529.
Ball, EM, Gibson, David, Bell, AL and Rooney, MR (2014) Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus.. Lupus, 23 (1). pp. 45-56.
Finnegan, S, Robson, J, Scaife, C, McAllister, C, Pennington, SR, Gibson, David and Rooney, ME (2014) Synovial membrane protein expression differs between juvenile idiopathic arthritis subtypes in early disease. Arthritis Research and Therapy, 16 (1). pp. R8.
...
Duncan, Mark and Gibson, David (2012) Mass Spectrometry for Peptide and Protein Analysis. In: Encyclopedia of Analytical Chemistry. John Wiley & Sons, Ltd., Encyclopedia of Analytical Chemistry, pp. 1-22. ISBN ISBN: 9780470027318
...
Pattison, Sally, Johnston, E, Gibson, David, Pappin , D and Elborn, JS (2012) Proteomic analysis of the chronically infected CF airways. In: 35th European Cystic Fibrosis Conference, Dublin, Ireland. Elsevier B.V..
Gibson, David, Newell, Keri, Evans, Alexandra, Finnegan, Sorcha, Manning, Gwen, Scaife, Caitiona, McAllister, Catherine, Pennington, Stephen, Duncan, Mark, Moore, Terry and Rooney, Madeleine (2012) Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis. Journal of Proteomics, 75. pp. 5479-5492.
Gibson, David, Rooney, Madeleine, Finnegan, Sorcha, Qiu, Ji, Thompson, David, LaBaer, Joshua, Pennington, Stephen and Duncan, Mark (2012) Biomarkers in rheumatology, now and in the future. Rheumatology (Oxford), 51. pp. 423-433.
Gibson, David and Jordan, Grant (2012) AN INVESTIGATION INTO THE USE OF HUMAN BONE MARROW OSTEOGENIC CELLS IN THE TREATMENT OF BONE DEFECTS. In: British Orthopaedic Research Society (BORS), Cardiff, Wales, 12 - 13 July 2010. BRITISH EDITORIAL SOCIETY OF BONE AND JOINT SURGERY .
Finnegan, Sorcha, Clarke, Susan, Gibson, David, McAllister, Catherine and Rooney, Madeleine (2011) Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups. Annals of the Rheumatic Diseases, 70. pp. 1842-1850.
Duncan, MW and Gibson, David (2011) Intact Protein Quantification by Mass Spectrometry . In: Mass Spectrometry Applications to the Clinical Lab, San Diego, CA, USA. MSACL, Inc. 281-282


After his Biochemistry degree, ...

www.biomed.science.ulster.ac.uk [cached]

After his Biochemistry degree, Dr David Gibson worked at Randox Laboratories Ltd, where he was responsible for designing and commercializing novel biochip array diagnostic tests. He was awarded a Ph.D. in 2001 from the Centre for Cancer Research and Cell Biology, Queen's University Belfast, for research which exposed the role of cysteine proteinases in brain tumour invasion. During a Wellcome Trust Fellowship Dr Gibson investigated the role of inflammation in a hypoxia driven model of diabetic retinopathy at the Centre of Vision and Vascular Science, QUB.

Since 2003 Dr Gibson focused his research efforts on the discovery and validation of protein biomarkers which could improve the management of arthritis patients. During his time at the Rooney laboratory in the Centre of Infection and Immunity, QUB he spearheaded the use of proteomic and bioinformatic strategies to identify a plasma and synovial fluid protein 'fingerprint' that predicts disease spread in children with arthritis. He also identified post translational modifications in the Vitamin D binding protein that may act as a modulator of inflammation in juvenile arthritis patients.
In 2009, Dr Gibson was awarded a prestigious travel fellowship from Arthritis Research UK to conduct research at the Duncan laboratory at the University of Colorado, Denver over two years. From this fellowship Dr Gibson brings expertise in mass spectrometry analyses of clinically relevant proteins, peptides and post-translational modifications to his current post at the University of Ulster.
Research Interests
Stratified Medicine- 'the right treatment, for the right person, at the right time'
In 2013 Dr Gibson took up his post as Lecturer in Stratified Medicine and his research is focused on adult rheumatoid arthritis (RA). He is particularly interested in the development of new prognostic and predictive tools to improve the clinical management of arthritis patients. David's current research within the Northern Ireland Centre for Stratified Medicine is based at C-TRIC within the Altnagelvin Hospital campus, Londonderry.
He employs novel mass spectrometry based methods to robustly identify and quantify disease associated proteins. These methods are useful to investigate the role of protein modification in arthritis, as a surrogate measure of inflammatory activity. He is also interested in the application of protein array technologies for autoantibody screening. He will initially establish research programmes in three key areas: 1. How RA patients develop resistance to biologic therapies. 2. How inflammation and joint destruction can persist without clinical symptoms. 3. Can alternate methods of blood sampling support patient care away from the hospital clinic. Ultimately, Dr Gibson will develop novel monitoring tools to help clinicians target those patients who do not respond well to current therapeutics or develop drug resistance over time.
...
Dr David Gibson Lecturer in Stratified Medicine Biomedical Sciences Research Institute
...
Collins, ES, Butt, AQ, Gibson, DS, Dunn, M, Fearon, U, van Kuijk , AW, Gerlag , DM, Pontifex, E, Veale , DJ, Tak, PP, Fitzgerald, O and Pennington , SR (2015) A Clinically Based Protein Discovery Strategy to Identify Potential Biomarkers of Response to Anti-TNF-alpha Treatment of Psoriatic Arthritis. Proteomics Clinical Applications, ?.
Butt, Aisha Q, McArdle, Angela, Gibson, David, Fitzgerald, Oliver and Pennington, Stephen R (2015) Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management. Current Rheumatology Reports, 17 (5). pp. 509.
Bian, X, Wiktor, P, Kahn, P, Khela , A, Karthikeyan, K, Barker, K, Yu, X, Magee, M, Wasserfall, CH, Gibson, David, Rooney, ME, Qiu, J and LaBaer, J (2015) Anti-viral antibody profiling by high density protein arrays.. Proteomics, Tbc.
...
Duncan, Mark W, Gibson, David , Walsh, Ryan, Massod, Afsham and Benabdelkamel, Hicham (2014) An Overview of Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry and Some of Its Applications. In: Detection of Chemical, Biological, Radiological and Nuclear Agents for the Prevention of Terrorism, NATO Science for Peace and Security Series A: Chemistry and Biology. Springer Science, Dordrecht, Germany, pp. 69-81. ISBN 978-94-017-9237-0
Alfadda , AA, Turjoman , AA, Moustafa , AS, Al-Naami , MY, Chishti , MA, Sallam , RM, Gibson, David and Duncan, MW (2014) A proteomic analysis of excreted and circulating proteins from obese patients following two different weight-loss strategies. Exp Biol Med , 239 (5). pp. 568-580.
Shyamsundar , M, McAuley , DF, Ingram , RJ, Gibson, David, O'Kane , D, McKeown , ST, Edwards , A, Taggart , C, Elborn , JS, Calfee , CS, Matthay, MA and O'Kane , CM (2014) Keratinocyte Growth-Factor Promotes Epithelial Survival and Resolution in a Human Model of Lung Injury. Am J Respir Crit Care Med, 189 (12). pp. 1520-1529.
Ball, EM, Gibson, David, Bell, AL and Rooney, MR (2014) Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus.. Lupus, 23 (1). pp. 45-56.
Finnegan, S, Robson, J, Scaife, C, McAllister, C, Pennington, SR, Gibson, David and Rooney, ME (2014) Synovial membrane protein expression differs between juvenile idiopathic arthritis subtypes in early disease. Arthritis Research and Therapy, 16 (1). pp. R8.
...
Duncan, Mark and Gibson, David (2012) Mass Spectrometry for Peptide and Protein Analysis. In: Encyclopedia of Analytical Chemistry. John Wiley & Sons, Ltd., Encyclopedia of Analytical Chemistry, pp. 1-22. ISBN ISBN: 9780470027318
...
Pattison, Sally, Johnston, E, Gibson, David, Pappin , D and Elborn, JS (2012) Proteomic analysis of the chronically infected CF airways. In: 35th European Cystic Fibrosis Conference, Dublin, Ireland. Elsevier B.V..
Gibson, David, Newell, Keri, Evans, Alexandra, Finnegan, Sorcha, Manning, Gwen, Scaife, Caitiona, McAllister, Catherine, Pennington, Stephen, Duncan, Mark, Moore, Terry and Rooney, Madeleine (2012) Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis. Journal of Proteomics, 75. pp. 5479-5492.
Gibson, David, Rooney, Madeleine, Finnegan, Sorcha, Qiu, Ji, Thompson, David, LaBaer, Joshua, Pennington, Stephen and Duncan, Mark (2012) Biomarkers in rheumatology, now and in the future. Rheumatology (Oxford), 51. pp. 423-433.
Gibson, David and Jordan, Grant (2012) AN INVESTIGATION INTO THE USE OF HUMAN BONE MARROW OSTEOGENIC CELLS IN THE TREATMENT OF BONE DEFECTS. In: British Orthopaedic Research Society (BORS), Cardiff, Wales, 12 - 13 July 2010. BRITISH EDITORIAL SOCIETY OF BONE AND JOINT SURGERY .
Finnegan, Sorcha, Clarke, Susan, Gibson, David, McAllister, Catherine and Rooney, Madeleine (2011) Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups. Annals of the Rheumatic Diseases, 70. pp. 1842-1850.
Duncan, MW and Gibson, David (2011) Intact Protein Quantification by Mass Spectrometry . In: Mass Spectrometry Applications to the Clinical Lab, San Diego, CA, USA. MSACL, Inc. 281-282


Gibson, David Dr - Biomedical Sciences

www.bioinformatics.ulster.ac.uk [cached]

After his Biochemistry degree, Dr David Gibson worked at Randox Laboratories Ltd, where he was responsible for designing and commercializing novel biochip array diagnostic tests. He was awarded a Ph.D. in 2001 from the Centre for Cancer Research and Cell Biology, Queen's University Belfast, for research which exposed the role of cysteine proteinases in brain tumour invasion. During a Wellcome Trust Fellowship Dr Gibson investigated the role of inflammation in a hypoxia driven model of diabetic retinopathy at the Centre of Vision and Vascular Science, QUB.

Since 2003 Dr Gibson focused his research efforts on the discovery and validation of protein biomarkers which could improve the management of arthritis patients. During his time at the Rooney laboratory in the Centre of Infection and Immunity, QUB he spearheaded the use of proteomic and bioinformatic strategies to identify a plasma and synovial fluid protein 'fingerprint' that predicts disease spread in children with arthritis. He also identified post translational modifications in the Vitamin D binding protein that may act as a modulator of inflammation in juvenile arthritis patients.
In 2009, Dr Gibson was awarded a prestigious travel fellowship from Arthritis Research UK to conduct research at the Duncan laboratory at the University of Colorado, Denver over two years. From this fellowship Dr Gibson brings expertise in mass spectrometry analyses of clinically relevant proteins, peptides and post-translational modifications to his current post at the University of Ulster.
Research Interests
Stratified Medicine- 'the right treatment, for the right person, at the right time'
In 2013 Dr Gibson took up his post as Lecturer in Stratified Medicine and his research is focused on adult rheumatoid arthritis (RA). He is particularly interested in the development of new prognostic and predictive tools to improve the clinical management of arthritis patients. David's current research within the Northern Ireland Centre for Stratified Medicine is based at C-TRIC within the Altnagelvin Hospital campus, Londonderry.
He employs novel mass spectrometry based methods to robustly identify and quantify disease associated proteins. These methods are useful to investigate the role of protein modification in arthritis, as a surrogate measure of inflammatory activity. He is also interested in the application of protein array technologies for autoantibody screening. He will initially establish research programmes in three key areas: 1. How RA patients develop resistance to biologic therapies. 2. How inflammation and joint destruction can persist without clinical symptoms. 3. Can alternate methods of blood sampling support patient care away from the hospital clinic. Ultimately, Dr Gibson will develop novel monitoring tools to help clinicians target those patients who do not respond well to current therapeutics or develop drug resistance over time.
...
Dr David Gibson Lecturer in Stratified Medicine Biomedical Sciences Research Institute
...
Collins, ES, Butt, AQ, Gibson, DS, Dunn, M, Fearon, U, van Kuijk , AW, Gerlag , DM, Pontifex, E, Veale , DJ, Tak, PP, Fitzgerald, O and Pennington , SR (2015) A Clinically Based Protein Discovery Strategy to Identify Potential Biomarkers of Response to Anti-TNF-alpha Treatment of Psoriatic Arthritis. Proteomics Clinical Applications, ?.
Butt, Aisha Q, McArdle, Angela, Gibson, David, Fitzgerald, Oliver and Pennington, Stephen R (2015) Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management. Current Rheumatology Reports, 17 (5). pp. 509.
Bian, X, Wiktor, P, Kahn, P, Khela , A, Karthikeyan, K, Barker, K, Yu, X, Magee, M, Wasserfall, CH, Gibson, David, Rooney, ME, Qiu, J and LaBaer, J (2015) Anti-viral antibody profiling by high density protein arrays.. Proteomics, Tbc.
...
Duncan, Mark W, Gibson, David , Walsh, Ryan, Massod, Afsham and Benabdelkamel, Hicham (2014) An Overview of Matrix-Assisted Laser Desorption/Ionization (MALDI) Mass Spectrometry and Some of Its Applications. In: Detection of Chemical, Biological, Radiological and Nuclear Agents for the Prevention of Terrorism, NATO Science for Peace and Security Series A: Chemistry and Biology. Springer Science, Dordrecht, Germany, pp. 69-81. ISBN 978-94-017-9237-0
Alfadda , AA, Turjoman , AA, Moustafa , AS, Al-Naami , MY, Chishti , MA, Sallam , RM, Gibson, David and Duncan, MW (2014) A proteomic analysis of excreted and circulating proteins from obese patients following two different weight-loss strategies. Exp Biol Med , 239 (5). pp. 568-580.
Shyamsundar , M, McAuley , DF, Ingram , RJ, Gibson, David, O'Kane , D, McKeown , ST, Edwards , A, Taggart , C, Elborn , JS, Calfee , CS, Matthay, MA and O'Kane , CM (2014) Keratinocyte Growth-Factor Promotes Epithelial Survival and Resolution in a Human Model of Lung Injury. Am J Respir Crit Care Med, 189 (12). pp. 1520-1529.
Ball, EM, Gibson, David, Bell, AL and Rooney, MR (2014) Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus.. Lupus, 23 (1). pp. 45-56.
Finnegan, S, Robson, J, Scaife, C, McAllister, C, Pennington, SR, Gibson, David and Rooney, ME (2014) Synovial membrane protein expression differs between juvenile idiopathic arthritis subtypes in early disease. Arthritis Research and Therapy, 16 (1). pp. R8.
...
Duncan, Mark and Gibson, David (2012) Mass Spectrometry for Peptide and Protein Analysis. In: Encyclopedia of Analytical Chemistry. John Wiley & Sons, Ltd., Encyclopedia of Analytical Chemistry, pp. 1-22. ISBN ISBN: 9780470027318
...
Pattison, Sally, Johnston, E, Gibson, David, Pappin , D and Elborn, JS (2012) Proteomic analysis of the chronically infected CF airways. In: 35th European Cystic Fibrosis Conference, Dublin, Ireland. Elsevier B.V..
Gibson, David, Newell, Keri, Evans, Alexandra, Finnegan, Sorcha, Manning, Gwen, Scaife, Caitiona, McAllister, Catherine, Pennington, Stephen, Duncan, Mark, Moore, Terry and Rooney, Madeleine (2012) Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis. Journal of Proteomics, 75. pp. 5479-5492.
Gibson, David, Rooney, Madeleine, Finnegan, Sorcha, Qiu, Ji, Thompson, David, LaBaer, Joshua, Pennington, Stephen and Duncan, Mark (2012) Biomarkers in rheumatology, now and in the future. Rheumatology (Oxford), 51. pp. 423-433.
Gibson, David and Jordan, Grant (2012) AN INVESTIGATION INTO THE USE OF HUMAN BONE MARROW OSTEOGENIC CELLS IN THE TREATMENT OF BONE DEFECTS. In: British Orthopaedic Research Society (BORS), Cardiff, Wales, 12 - 13 July 2010. BRITISH EDITORIAL SOCIETY OF BONE AND JOINT SURGERY .
Finnegan, Sorcha, Clarke, Susan, Gibson, David, McAllister, Catherine and Rooney, Madeleine (2011) Synovial membrane immunohistology in early untreated juvenile idiopathic arthritis: differences between clinical subgroups. Annals of the Rheumatic Diseases, 70. pp. 1842-1850.
Duncan, MW and Gibson, David (2011) Intact Protein Quantification by Mass Spectrometry . In: Mass Spectrometry Applications to the Clinical Lab, San Diego, CA, USA. MSACL, Inc. 281-282

Similar Profiles

Other People with this Name

Other people with the name Gibson

Michael Gibson
Castleberry Hill

Steve Gibson
Timberland Harvesters LLC

Christa Gibson
Powhatan Animal Hospital Inc

Don Gibson
Crown Harbor Association

Trevor Gibson

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory